Ferguson Wellman Capital Management Inc. Boosts Holdings in Danaher Co. (NYSE:DHR)

Ferguson Wellman Capital Management Inc. grew its position in shares of Danaher Co. (NYSE:DHR) by 17.5% during the second quarter, HoldingsChannel reports. The firm owned 1,785 shares of the conglomerate’s stock after buying an additional 266 shares during the period. Ferguson Wellman Capital Management Inc.’s holdings in Danaher were worth $446,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in DHR. Cape Investment Advisory Inc. acquired a new stake in shares of Danaher during the fourth quarter worth approximately $25,000. Tsfg LLC boosted its holdings in Danaher by 733.3% in the first quarter. Tsfg LLC now owns 100 shares of the conglomerate’s stock worth $25,000 after purchasing an additional 88 shares during the period. Wetzel Investment Advisors Inc. acquired a new position in Danaher in the fourth quarter worth $29,000. Redmont Wealth Advisors LLC acquired a new position in Danaher in the first quarter worth $30,000. Finally, Rakuten Securities Inc. acquired a new position in Danaher in the fourth quarter worth $36,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the stock. Barclays boosted their price target on shares of Danaher from $270.00 to $285.00 and gave the company an “equal weight” rating in a report on Wednesday, July 24th. Citigroup lifted their price objective on shares of Danaher from $280.00 to $290.00 and gave the company a “buy” rating in a research note on Wednesday, April 24th. Evercore ISI cut their price objective on shares of Danaher from $266.00 to $260.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 2nd. Jefferies Financial Group assumed coverage on shares of Danaher in a research note on Monday, June 3rd. They set a “buy” rating and a $295.00 price objective on the stock. Finally, SVB Leerink lifted their price objective on shares of Danaher from $275.00 to $280.00 and gave the company an “outperform” rating in a research note on Wednesday, July 24th. Six investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to MarketBeat.com, Danaher currently has an average rating of “Moderate Buy” and a consensus target price of $276.88.

Insiders Place Their Bets

In other Danaher news, CFO Matthew Mcgrew sold 16,172 shares of Danaher stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $279.84, for a total transaction of $4,525,572.48. Following the transaction, the chief financial officer now owns 29,407 shares of the company’s stock, valued at approximately $8,229,254.88. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In related news, CEO Rainer Blair sold 9,005 shares of the business’s stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $265.00, for a total value of $2,386,325.00. Following the completion of the sale, the chief executive officer now owns 106,990 shares of the company’s stock, valued at approximately $28,352,350. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, CFO Matthew Mcgrew sold 16,172 shares of the business’s stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $279.84, for a total value of $4,525,572.48. Following the completion of the sale, the chief financial officer now directly owns 29,407 shares of the company’s stock, valued at approximately $8,229,254.88. The disclosure for this sale can be found here. In the last quarter, insiders have sold 47,712 shares of company stock worth $13,173,269. Company insiders own 11.10% of the company’s stock.

Danaher Trading Down 0.2 %

NYSE DHR traded down $0.58 on Wednesday, hitting $268.13. 923,732 shares of the company were exchanged, compared to its average volume of 2,873,703. The company’s 50 day moving average price is $257.53 and its 200-day moving average price is $252.98. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.04. The firm has a market capitalization of $198.60 billion, a P/E ratio of 45.54, a price-to-earnings-growth ratio of 4.62 and a beta of 0.83. Danaher Co. has a twelve month low of $182.09 and a twelve month high of $281.70.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, July 23rd. The conglomerate reported $1.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.15. The firm had revenue of $5.74 billion for the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a return on equity of 11.06% and a net margin of 16.94%. The business’s revenue for the quarter was down 2.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.05 EPS. Analysts predict that Danaher Co. will post 7.59 earnings per share for the current fiscal year.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.